BFC Planning’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Other funds holding AMRX
BFC Planning's AMRX Position: Q3 2026 in Review
BFC Planning opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 70 shares worth $1.41K. The stake represents ﹤0.01% of the portfolio and ranks #3096 among its holdings.
264 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.
- BFC Planning held 70 shares of Amneal Pharmaceuticals worth $1.41K as of Q3 2026.
- Amneal Pharmaceuticals was a new BFC Planning position in Q3 2026.
- Amneal Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3096 holding.
- 264 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.